Study: Trongtorsak 2025, Circulation: Arrhythmia and Electrophysiology

Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium

Citation

Trongtorsak A, De La Rosa Martinez J, Crawford TC, Bogun FM et al (2025). Circulation: Arrhythmia and Electrophysiology. PubMed id 40557494.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Sarcoidosis: symptoms, risk and follow-up Tier B thin

    B 619 patients with cardiac sarcoidosis (362 White, 193 Black, 64 other) in an international registry of over 25 centres (n=619)

    Registry cohort comparing race groups.

    Black patients were diagnosed younger (50.5 against 53.7 years) with lower left ventricular ejection fraction (44.6 against 48.3) and more lung (80.3% against 72.7%), skin (22.8% against 12.4%) and eye (13.5% against 5.5%) involvement, and more hypertension, diabetes and kidney disease. Treatment patterns were similar and the combined outcome (death, assist device, transplant or defibrillator therapy) did not differ (29.5% against 28.5%).

    As recorded in this card: Trongtorsak A, De La Rosa Martinez J, Crawford TC, Bogun FM et al (2025), Circulation: Arrhythmia and Electrophysiology, [primary]

    Note: People with heart sarcoidosis only, mostly from specialist centres; not all patients with sarcoidosis.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.